Proteomics International launches new IPO

Emerging life science company Proteomics International Laboratories Ltd (proposed ASX: PIQ) is pleased to announce that it has launched its prospectus for a new IPO to raise up to $6 million via the issue of 30 million shares at 20c each.

Media release


  • This field is for validation purposes and should be left unchanged.